Open AccessSafety and efficacy of topical agents in primary open angle glaucoma- latanoprost versus combination of latanoprost & timolol maleate
Author(s) -
SK Agarwal,
Sugyani Satapathy,
Mukta Prasad
Publication year - 2021
Publication title -
ip international journal of ocular oncology and oculoplasty/ip international journal of ocular oncology and oculoplasty
Language(s) - English
Resource type - Journals
eISSN - 2581-5016
pISSN - 2581-5024
DOI - 10.18231/j.ijooo.2021.059
Subject(s) - latanoprost , timolol , medicine , glaucoma , open angle glaucoma , ophthalmology , anesthesia
This prospective drug trial was done to compare latanoprost versus combination therapy of latanoprost and timolol maleate. Patient were screened for primary open angle glaucoma and grouped as per pharmacological drugs used and measured IOP baseline before initiation of study. Group I consisting all patients with latanoprost monotherapy and Group II consisting of patients already using either latanoprost or timolol. Further A,B & C was assigned as per IOP baseline. In group I (Monotherapy), 28 patients were completed the follow up. The mean baseline IOP was 27.4 millimeter of Hg with standard deviation of 2.59. After 12 weeks of study, mean IOP was 19.66 millimeter of Hg with SD of 2.76. Mean IOP difference from baseline was 7.4 millimeter of Hg. So fall of 27.3% in IOP from pre-treatment level. In group II (Combination therapy), 19 patients were completed the follow up. The mean baseline IOP was 27.35 millimeter of Hg with standard deviation of 2.6. After 12 weeks of study mean IOP difference from baseline was 8.1 millimeter of Hg with SD of 2.0 millimeter of Hg i.e. a fall of 29.63% in IOP from pre-treatment level. Combination therapy fared slightly better that Latanoprost alone in overall pressure reduction.